The "Preventing Overdiagnosis" conference covers how physicians, researchers and patients can implement solutions to the problems of overdiagnosis and overuse in the healthcare system. A strict policy of no industry funding or sponsorship, either direct or indirect, applies to all Preventing Overdiagnosis conferences and associated activities.

• Equity & Equality: disparities in healthcare provision, marginalized populations, conflicts of interest driving inequity.
  AP. Loai Alboquari (AUS) – Prof. France Légaré (CA) – Dr. Nav Persaud (CA)
   
• Sustainability and lessons learned from COVID-19: repurposing healthcare after a pandemic.
  Dr. Minna Johansson (SE) – Dr. Deborah Korenstein (US) – Dr. Wendy Levinson (CA)
   
• The role of specialists in generating Overdiagnosis and their efforts to mitigate it
  AP. Luis Correia (BR) – Prof. Laura Esserman (US) – Ms. Luise Kazda (AUS)
   
• Medicalizing citizens: the harms of screening, disease thresholds, industry influences, the role of media.
  Prof. Allen Frances (US) – Prof. Shelly Hwang (US) – Dr. James Dickinson (CA)
   
• Promotional messaging vs neutral messaging – impact on individual breast screening decisions when information is suppressed.
  Dr. Cécile Bour (FR) – Dr. Mette Kalager (NO) – Prof. Scott Klarenbach (CA)
   
• Clinical Practice: Other dimensions of ODx, overtesting and the harms of too much medicine.
  Prof. Otis Brawley (US) – Marisa Vigna (CA)
   
• The role of health systems and performance measures in Overdiagnosis.
  Prof. Todd Anderson (CA) – Dr. Fiona Clement (CA) – Dr. Jessica Otte (CA) - Anni Rychtera  CA)

For details and to register: > www.preventingoverdiagnosis.net

©Prescrire 10 May 2022